Tregs are believed to accumulate in response to cytokines and chemokines released in the tumor microenvironment (TME) by dysplastic cells and tumor stroma infiltrating cells, to suppress the anti-tumor activity mediated by natural killer (NK) and cytotoxic CD8+ T cells and to favor tumor progression [3]. Here, CD8A is linked to neoplasm.